Related Experiment Video
Updated: Jun 29, 2025

03:24
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
1.5K
Intractable Nocardial mycetoma with possible colonisation by Candida species
Ayano Sumioki1, Kanami Saito1, Haruto Nishida2
1Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
The Journal of Dermatology
|April 1, 2024
Summary
A rare case of mycetoma caused by Nocardia vulneris in an immunocompetent patient was successfully treated with a combination antifungal and antibiotic therapy. The infection, potentially complicated by co-infecting yeasts, required a multi-drug approach for effective management.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Dermatology
Background:
- Mycetoma is a chronic, granulomatous infectious disease affecting subcutaneous tissue, typically caused by fungi or aerobic actinomycetes.
- Nocardia species are known causative agents of mycetoma, often presenting as localized infections.
Observation:
- A Japanese male in his 30s presented with a 7-year history of painless nodules and ulcers on his right leg following a dog bite in Bali, Indonesia.
- Tissue cultures revealed Nocardia vulneris as the primary pathogen, with concurrent isolation of Candida parapsilosis and Candida tropicalis.
Findings:
- The patient was diagnosed with mycetoma attributed to Nocardia vulneris, potentially complicated by co-infection with Candida species.
- Initial treatment with minocycline hydrochloride and sulfamethoxazole trimethoprim showed limited efficacy.
- Addition of posaconazole resulted in significant clinical improvement, suggesting synergistic or additive effects.
Implications:
- This case highlights the potential for Nocardia vulneris to cause mycetoma in immunocompetent individuals.
- Co-colonization with less virulent yeasts may complicate treatment, necessitating a comprehensive therapeutic strategy.
- Combination therapy including antifungals like posaconazole may be crucial for managing recalcitrant mycetoma cases.

